Universal Ibogaine Inc V.IBO

Alternate Symbol(s): IBOGF

Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The Company is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which paired with the planned ibogaine detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction. Ibogaine is a naturally occurring molecule derived from the root bark of the iboga tree and other plants. It is a potent and serious medical psychedelic which has addiction interrupting properties. Ibogaine targets multiple receptors across multiple sites in the brain and metabolizes into noribogaine, a serotonin re-uptake inhibitor that remains in the body for 1-4 months, associated with elimination of addictive cravings.

TSXV:IBO - Post by User

Universal Ibogaine Inc

<< Previous

Bullboard Posts

Next >>

Post by DRJENNYon Jul 07, 2022 2:09pm

67 Views

Post# 34809063

$IBO announced a vital addition of clinical trials director

Julie Dumouchel has been named Director of Clinical Trials at UI, which is a huge key move. Julie Dumouchel has 25 years of involvement with the drug area,where she has worked in a variety of clinical research jobs and has a thorough grasp of the drug development process.

<< Previous

Bullboard Posts

Next >>

Canopy Growth nears adjusted EBITDA profitability in Q2 2025